urea has been researched along with Arrhythmias, Cardiac in 45 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Landiolol hydrochloride, a highly cardio-selective beta-1 blocker with an ultra-short-acting half-life of 4 minutes, was originally approved by Japan for treatment of intraoperative tachyarrhythmias." | 9.05 | Evaluating the Therapeutic Efficacy and Safety of Landiolol Hydrochloride for Management of Arrhythmia in Critical Settings: Review of the Literature. ( Inoue, Y; Kawano, S; Mathis, BJ; Matsuishi, Y; Shimojo, N, 2020) |
| "We report successful anesthetic management of a patient with pheochromocytoma using high-dose landiolol hydrochloride." | 7.80 | [Successful anesthetic management of a patient with giant pheochromocytoma using high-dose landiolol hydrochloride]. ( Kitano, M; Komasawa, N; Minami, T; Sawai, T, 2014) |
| "The objectives of this study were to evaluate the dose-dependent effects of landiolol, an ultra-short-acting β1-blocker, as well as the effectiveness and safety of the drug in suppressing supraventricular tachyarrhythmias (SVT) in postoperative patients." | 7.79 | Dose-dependent effect of landiolol, a new ultra-short-acting β(1)-blocker, on supraventricular tachyarrhythmias in postoperative patients. ( Kikawa, S; Taenaka, N, 2013) |
| "The purpose of this study was to determine whether a low-dose β-blocker, in combination with milrinone, improves cardiac function in acute decompensated heart failure (ADHF) with tachycardia." | 7.78 | Low-dose β-blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure. ( Doi, M; Fukuta, S; Kobayashi, S; Matsuzaki, M; Murakami, W; Nao, T; Okamura, T; Okuda, S; Susa, T; Tanaka, T; Wada, Y; Yamada, J; Yano, M, 2012) |
| "The purpose of this study was to investigate the efficacy of landiolol hydrochloride, a short-acting beta(1) blocker, by initiating its administration at a low dose (5 microg kg(-1) min(-1)) in patients with postoperative supraventricular arrhythmia." | 7.75 | Postoperative administration of landiolol hydrochloride for patients with supraventricular arrhythmia: the efficacy of sustained intravenous infusion at a low dose. ( Fukutomi, T; Nishimori, H; Radhakrishnan, G; Sasaguri, S; Wariishi, S; Yamamoto, M; Yamashita, K, 2009) |
| " Serum levels were significantly higher at 8 and 24 hours in those patients who received their first dose intramuscularly compared with those who received their first dose orally, irrespective of the bioavailability of the oral preparation used." | 5.25 | Treatment with digoxin and measurement of serum digoxin levels after myocardial infarction. ( McL White, B; Norris, RM; Sharpe, DN, 1975) |
| "Landiolol hydrochloride, a highly cardio-selective beta-1 blocker with an ultra-short-acting half-life of 4 minutes, was originally approved by Japan for treatment of intraoperative tachyarrhythmias." | 5.05 | Evaluating the Therapeutic Efficacy and Safety of Landiolol Hydrochloride for Management of Arrhythmia in Critical Settings: Review of the Literature. ( Inoue, Y; Kawano, S; Mathis, BJ; Matsuishi, Y; Shimojo, N, 2020) |
| "Omecamtiv mecarbil (OM) is a myosin activator (myotrope), developed as a potential therapeutic agent for heart failure with reduced ejection fraction." | 4.02 | Comprehensive in vitro pro-arrhythmic assays demonstrate that omecamtiv mecarbil has low pro-arrhythmic risk. ( Arimura, Z; Fang, M; Gao, B; Qu, Y; Vargas, HM, 2021) |
| "We report successful anesthetic management of a patient with pheochromocytoma using high-dose landiolol hydrochloride." | 3.80 | [Successful anesthetic management of a patient with giant pheochromocytoma using high-dose landiolol hydrochloride]. ( Kitano, M; Komasawa, N; Minami, T; Sawai, T, 2014) |
| "The objectives of this study were to evaluate the dose-dependent effects of landiolol, an ultra-short-acting β1-blocker, as well as the effectiveness and safety of the drug in suppressing supraventricular tachyarrhythmias (SVT) in postoperative patients." | 3.79 | Dose-dependent effect of landiolol, a new ultra-short-acting β(1)-blocker, on supraventricular tachyarrhythmias in postoperative patients. ( Kikawa, S; Taenaka, N, 2013) |
| "The purpose of this study was to determine whether a low-dose β-blocker, in combination with milrinone, improves cardiac function in acute decompensated heart failure (ADHF) with tachycardia." | 3.78 | Low-dose β-blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure. ( Doi, M; Fukuta, S; Kobayashi, S; Matsuzaki, M; Murakami, W; Nao, T; Okamura, T; Okuda, S; Susa, T; Tanaka, T; Wada, Y; Yamada, J; Yano, M, 2012) |
| "The purpose of this study was to investigate the efficacy of landiolol hydrochloride, a short-acting beta(1) blocker, by initiating its administration at a low dose (5 microg kg(-1) min(-1)) in patients with postoperative supraventricular arrhythmia." | 3.75 | Postoperative administration of landiolol hydrochloride for patients with supraventricular arrhythmia: the efficacy of sustained intravenous infusion at a low dose. ( Fukutomi, T; Nishimori, H; Radhakrishnan, G; Sasaguri, S; Wariishi, S; Yamamoto, M; Yamashita, K, 2009) |
| "Urea can inhibit the sodium currents of ventricular myocyte in mice to make it happen conduction block arrhythmia." | 3.75 | [The effects of urea on ECG and the sodium currents of ventricular myocyte in mice]. ( Xi, SG; Zhang, XX; Zhao, CY, 2009) |
| "Incidences of arrhythmia, muscular cramps and headache were significantly less frequent during HF." | 2.68 | On-line predilution hemofiltration versus ultrapure high-flux hemodialysis: a multicenter prospective study in 23 patients. Sardinian Collaborative Study Group of On-Line Hemofiltration. ( Altieri, P; Asproni, E; Bolasco, F; Bolasco, PG; Bostrom, M; Cabiddu, GF; Cadinu, F; Casu, D; Cossu, M; Ferrara, R; Ganadu, M; Passaghe, M; Pinna, M; Sorba, GB, 1997) |
| "The incidence of arrhythmias was assessed by in vivo electrophysiologic studies." | 1.48 | Soluble epoxide hydrolase inhibitors, t-AUCB, downregulated miR-133 in a mouse model of myocardial infarction. ( Chen, J; Deng, L; Du, X; Gui, Y; Hu, J; Li, D; Liao, C; Wang, Y; Xiang, Q; Xu, D; Yang, T; Zhang, S, 2018) |
| "Ischemic arrhythmias are the main causes of sudden cardiac death." | 1.46 | Soluble epoxide hydrolase inhibitors might prevent ischemic arrhythmias via microRNA-1 repression in primary neonatal mouse ventricular myocytes. ( Gui, YJ; Liao, CX; Liu, Q; Peng, R; Wang, M; Xu, DY; Zhao, W; Zhao, X, 2017) |
| "Inducibility of ventricular arrhythmias was examined by programmed stimulation." | 1.31 | Salutary antiarrhythmic effect of combining a K channel blocker and a beta-blocker in a canine model of 7-day-old myocardial infarction. ( Kanki, H; Mitamura, H; Ogawa, S; Sueyoshi, K; Takatsuki, S, 2000) |
| "Total starvation is effective for acute weight reduction in obesity." | 1.26 | [Complications in null-diet]. ( Mordasini, R; Oster, P; Raetzer, H; Schellenberg, B; Schlierf, G, 1977) |
| "Metabolic acidosis was mainly due to a marked increase in the concentration of lactic acid in the serum." | 1.26 | [Biochemical changes in the blood of calves with scours and their correction by fluid therapy (author's transl)]. ( Dallenga, HH, 1976) |
| "1 The tendency of a given oral dose of digoxin to induce cardiac dysrhythmia was determined indirectly at various times after its administration to eight conscious dogs by measurement of the intravenous dose of acetylstrophanthidin necessary to induce toxic changes in the ECG." | 1.26 | The relationship between cardiotoxicity and plasma digoxin concentration in conscious dogs. ( Chapple, DJ; Hughes, R; Johnson, BF, 1976) |
| " Serum levels were significantly higher at 8 and 24 hours in those patients who received their first dose intramuscularly compared with those who received their first dose orally, irrespective of the bioavailability of the oral preparation used." | 1.25 | Treatment with digoxin and measurement of serum digoxin levels after myocardial infarction. ( McL White, B; Norris, RM; Sharpe, DN, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (51.11) | 18.7374 |
| 1990's | 3 (6.67) | 18.2507 |
| 2000's | 5 (11.11) | 29.6817 |
| 2010's | 12 (26.67) | 24.3611 |
| 2020's | 2 (4.44) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuishi, Y | 1 |
| Mathis, BJ | 1 |
| Shimojo, N | 1 |
| Kawano, S | 1 |
| Inoue, Y | 1 |
| Qu, Y | 1 |
| Gao, B | 1 |
| Arimura, Z | 1 |
| Fang, M | 1 |
| Vargas, HM | 1 |
| Poveda-Jaramillo, R | 1 |
| Monaco, F | 1 |
| Zangrillo, A | 1 |
| Landoni, G | 1 |
| Gui, Y | 1 |
| Li, D | 1 |
| Chen, J | 1 |
| Wang, Y | 1 |
| Hu, J | 1 |
| Liao, C | 1 |
| Deng, L | 1 |
| Xiang, Q | 1 |
| Yang, T | 1 |
| Du, X | 1 |
| Zhang, S | 1 |
| Xu, D | 1 |
| Korkmaz, A | 1 |
| Yıldız, A | 1 |
| Kundi, H | 1 |
| Başyigit, F | 1 |
| Gürsoy, HT | 1 |
| Uçar Elalmış, Ö | 1 |
| Akyüz, A | 1 |
| İleri, M | 1 |
| Güray, Ü | 1 |
| Taenaka, N | 1 |
| Kikawa, S | 1 |
| Kitano, M | 1 |
| Komasawa, N | 1 |
| Sawai, T | 1 |
| Minami, T | 1 |
| Suzuki, K | 1 |
| Numaguchi, A | 1 |
| Adachi, YU | 1 |
| Obata, Y | 1 |
| Hatano, T | 1 |
| Ejima, T | 1 |
| Sato, S | 1 |
| Matsuda, N | 1 |
| Yang, B | 1 |
| Li, X | 1 |
| Guo, L | 1 |
| Meng, Y | 1 |
| Dong, Z | 1 |
| Zhao, X | 2 |
| Liu, Q | 1 |
| Peng, R | 1 |
| Wang, M | 1 |
| Zhao, W | 1 |
| Gui, YJ | 1 |
| Liao, CX | 1 |
| Xu, DY | 1 |
| Wariishi, S | 1 |
| Yamashita, K | 1 |
| Nishimori, H | 1 |
| Fukutomi, T | 1 |
| Yamamoto, M | 1 |
| Radhakrishnan, G | 1 |
| Sasaguri, S | 1 |
| Li, N | 1 |
| Liu, JY | 1 |
| Timofeyev, V | 1 |
| Qiu, H | 1 |
| Hwang, SH | 2 |
| Tuteja, D | 1 |
| Lu, L | 1 |
| Yang, J | 1 |
| Mochida, H | 1 |
| Low, R | 1 |
| Hammock, BD | 2 |
| Chiamvimonvat, N | 1 |
| Zhang, XX | 1 |
| Xi, SG | 1 |
| Zhao, CY | 1 |
| Neckář, J | 1 |
| Kopkan, L | 1 |
| Husková, Z | 1 |
| Kolář, F | 1 |
| Papoušek, F | 1 |
| Kramer, HJ | 1 |
| Imig, JD | 1 |
| Malý, J | 1 |
| Netuka, I | 1 |
| Ošťádal, B | 1 |
| Červenka, L | 1 |
| Kobayashi, S | 1 |
| Susa, T | 1 |
| Tanaka, T | 1 |
| Murakami, W | 1 |
| Fukuta, S | 1 |
| Okuda, S | 1 |
| Doi, M | 1 |
| Wada, Y | 1 |
| Nao, T | 1 |
| Yamada, J | 1 |
| Okamura, T | 1 |
| Yano, M | 1 |
| Matsuzaki, M | 1 |
| Yasumura, Y | 1 |
| Berta, E | 1 |
| Erdei, A | 1 |
| Cseke, B | 1 |
| Gazdag, A | 1 |
| Paragh, G | 1 |
| Balla, J | 1 |
| Polgar, P | 1 |
| Nagy, EV | 1 |
| Bodor, M | 1 |
| Ogata, J | 1 |
| Yokoyama, T | 1 |
| Okamoto, T | 1 |
| Minami, K | 1 |
| FOWLER, RS | 1 |
| RATHI, L | 1 |
| KEITH, JD | 1 |
| GARRETT, J | 1 |
| MOREIRA, G | 1 |
| OSSWALD, MW | 1 |
| GUIMARAES, S | 1 |
| HEWER, AJ | 1 |
| Wilcox, RG | 1 |
| Richardson, D | 1 |
| Hampton, JR | 1 |
| Mitchell, JR | 1 |
| Banks, DC | 1 |
| Evans, AE | 1 |
| Boyle, DM | 1 |
| Barber, JM | 1 |
| McIlmoyle, EL | 1 |
| Walsh, MJ | 1 |
| Chaturvedi, NC | 1 |
| Mackenzie, G | 1 |
| Elwood, JH | 1 |
| Altieri, P | 1 |
| Sorba, GB | 1 |
| Bolasco, PG | 1 |
| Bostrom, M | 1 |
| Asproni, E | 1 |
| Ferrara, R | 1 |
| Bolasco, F | 1 |
| Cossu, M | 1 |
| Cadinu, F | 1 |
| Cabiddu, GF | 1 |
| Casu, D | 1 |
| Ganadu, M | 1 |
| Passaghe, M | 1 |
| Pinna, M | 1 |
| Takatsuki, S | 1 |
| Mitamura, H | 1 |
| Kanki, H | 1 |
| Sueyoshi, K | 1 |
| Ogawa, S | 1 |
| Denis, B | 1 |
| Machecourt, J | 1 |
| Denis, MC | 1 |
| Morena, H | 1 |
| Pellet, J | 1 |
| Rossignol, B | 1 |
| Martin-Noël, P | 1 |
| Oster, P | 1 |
| Mordasini, R | 1 |
| Raetzer, H | 1 |
| Schellenberg, B | 1 |
| Schlierf, G | 1 |
| Dallenga, HH | 1 |
| Sharpe, DN | 1 |
| Norris, RM | 1 |
| McL White, B | 1 |
| Chapple, DJ | 1 |
| Hughes, R | 1 |
| Johnson, BF | 1 |
| Bach, R | 1 |
| Zardini, P | 1 |
| Woo, KS | 1 |
| Whittingham, S | 1 |
| Mackay, IR | 1 |
| Shaw, TR | 2 |
| Kumana, CR | 1 |
| Royds, RB | 1 |
| Padgham, CM | 1 |
| Hamer, J | 2 |
| Chopdar, A | 1 |
| Grabensee, B | 1 |
| Hofmann, K | 1 |
| Jax, W | 1 |
| Königshausen, T | 1 |
| Schnurr, E | 1 |
| Schröder, E | 1 |
| Casagrande, C | 1 |
| Galli, A | 1 |
| Ferrini, R | 1 |
| Miragoli, G | 1 |
| Ferrari, G | 1 |
| Howard, D | 1 |
| Smith, CI | 1 |
| Stewart, G | 1 |
| Vadas, M | 1 |
| Tiller, DJ | 1 |
| Hensley, WJ | 1 |
| Richards, JG | 1 |
| Raymond, K | 1 |
| Howard, MR | 1 |
| Joubert, PH | 1 |
| Müller, FO | 1 |
| Pansegrouw, DF | 1 |
| Ueyama, H | 1 |
| Johnston, CI | 1 |
| Pinkus, NB | 1 |
| Down, M | 1 |
| Zoll, PM | 1 |
| Evered, DC | 1 |
| Chapman, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Role of Innate and Adaptive Immunity After Acute Myocardial Infarction BATTLE-AMI Study (B And T Types of Lymphocytes Evaluation in Acute Myocardial Infarction)[NCT02428374] | Phase 4 | 300 participants (Anticipated) | Interventional | 2015-05-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for urea and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Evaluating the Therapeutic Efficacy and Safety of Landiolol Hydrochloride for Management of Arrhythmia in Critical Settings: Review of the Literature.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Critica | 2020 |
Ultra-Short-Acting β-Blockers (Esmolol and Landiolol) in the Perioperative Period and in Critically Ill Patients.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Cardiac S | 2018 |
Extrarenal phenotypes of the UT-B knockout mouse.
Topics: Animals; Arrhythmias, Cardiac; Biological Transport; Brain; Brugada Syndrome; Cardiac Conduction Sys | 2014 |
The management of intracranial hypertension and brain edema during and after general anesthesia.
Topics: Abdomen; Adrenal Cortex Hormones; Anesthesia, General; Arrhythmias, Cardiac; Blood Pressure; Brain E | 1971 |
5 trials available for urea and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Continuous administration of landiolol reduced QT dispersion in postoperative patients.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Dos | 2014 |
Sulphinpyrazone in acute myocardial infarction: studies on cardiac rhythm and renal function.
Topics: Arrhythmias, Cardiac; Clinical Trials as Topic; Creatinine; Double-Blind Method; Female; Humans; Mal | 1980 |
On-line predilution hemofiltration versus ultrapure high-flux hemodialysis: a multicenter prospective study in 23 patients. Sardinian Collaborative Study Group of On-Line Hemofiltration.
Topics: Aged; Arrhythmias, Cardiac; beta 2-Microglobulin; Bicarbonates; Body Weight; Electrolytes; Fatigue; | 1997 |
Long-acting angiotensin-converting enzyme inhibition: once-daily lisinopril versus twice-daily captopril in mild-to-moderate heart failure.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Cardiac; Capt | 1992 |
Therapeutic non-equivalence of digoxin tablets in the United Kingdom: correlation with tablet dissolution rate.
Topics: Administration, Oral; Arrhythmias, Cardiac; Creatinine; Digoxin; Female; Humans; Male; Middle Aged; | 1973 |
36 other studies available for urea and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Comprehensive in vitro pro-arrhythmic assays demonstrate that omecamtiv mecarbil has low pro-arrhythmic risk.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Computer Simulation; Dogs; Drug Evaluation, Precli | 2021 |
Soluble epoxide hydrolase inhibitors, t-AUCB, downregulated miR-133 in a mouse model of myocardial infarction.
Topics: Animals; Arrhythmias, Cardiac; Benzoates; Disease Models, Animal; Down-Regulation; ERG1 Potassium Ch | 2018 |
Can hemodialysis change QRS axis in patients without cardiovascular disease?
Topics: Adult; Aged; Arrhythmias, Cardiac; Cohort Studies; Creatinine; Electrocardiography; Female; Humans; | 2018 |
Dose-dependent effect of landiolol, a new ultra-short-acting β(1)-blocker, on supraventricular tachyarrhythmias in postoperative patients.
Topics: Adrenergic beta-Antagonists; Aged; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Female; H | 2013 |
[Successful anesthetic management of a patient with giant pheochromocytoma using high-dose landiolol hydrochloride].
Topics: Adrenal Gland Neoplasms; Analgesia, Epidural; Anesthesia, General; Arrhythmias, Cardiac; Catecholami | 2014 |
Soluble epoxide hydrolase inhibitors might prevent ischemic arrhythmias via microRNA-1 repression in primary neonatal mouse ventricular myocytes.
Topics: Animals; Animals, Newborn; Arrhythmias, Cardiac; Benzoates; Cell Survival; Cells, Cultured; Connexin | 2017 |
Postoperative administration of landiolol hydrochloride for patients with supraventricular arrhythmia: the efficacy of sustained intravenous infusion at a low dose.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; | 2009 |
Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches.
Topics: Animals; Apoptosis; Arrhythmias, Cardiac; Benzoates; Chromatography, Liquid; Cytokines; Disease Mode | 2009 |
[The effects of urea on ECG and the sodium currents of ventricular myocyte in mice].
Topics: Animals; Arrhythmias, Cardiac; Electrocardiography; Female; Heart Ventricles; Male; Membrane Transpo | 2009 |
Inhibition of soluble epoxide hydrolase by cis-4-[4-(3-adamantan-1-ylureido)cyclohexyl-oxy]benzoic acid exhibits antihypertensive and cardioprotective actions in transgenic rats with angiotensin II-dependent hypertension.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Benzoates; Blood Pressure; C | 2012 |
Low-dose β-blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure.
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Cardiotonic Agents; C | 2012 |
Combination of β-blocker and milrinone for acute heart failure.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Cardiotonic Agents; Female; Heart Failure; Hemody | 2012 |
Evaluation of the metabolic changes during hemodialysis by signal averaged ECG.
Topics: Aged; Arrhythmias, Cardiac; Creatinine; Data Interpretation, Statistical; Electrocardiography; Elect | 2012 |
Managing a tachyarrhythmia in a patient with pheochromocytoma with landiolol, a novel ultrashort-acting beta-adrenergic blocker.
Topics: Adrenal Gland Neoplasms; Adrenergic beta-Antagonists; Anesthesia; Anti-Arrhythmia Agents; Arrhythmia | 2003 |
ACCIDENTAL DIGITALIS INTOXICATION IN CHILDREN.
Topics: Arrhythmia, Sinus; Arrhythmias, Cardiac; Blood Chemical Analysis; Blood Pressure; Blood Pressure Det | 1964 |
ANTIARRHYTHMIC ACTIVITY OF N,N-DIISOPROPYL-N'-ISOAMYL-N'-DIETHYLAMINOETHYLUREA HYDROCHLORIDE (P-286).
Topics: Acetylcholine; Aconitum; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, P | 1964 |
HYPOTHERMIA FOR NEUROSURGERY.
Topics: Anesthesia; Anesthesia, Inhalation; Anesthesia, Intravenous; Arrhythmias, Cardiac; Blood Transfusion | 1964 |
Safe selection of coronary patients for early discharge.
Topics: Age Factors; Aged; Arrhythmias, Cardiac; Electrocardiography; Female; Humans; Male; Myocardial Infar | 1981 |
Landiolol. ONO 1011.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drugs, Investiga | 1999 |
Salutary antiarrhythmic effect of combining a K channel blocker and a beta-blocker in a canine model of 7-day-old myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, | 2000 |
[Value of potassium canrenoate in the prevention of arrhythmia during the acute phase of myocardial infarction].
Topics: Acute Disease; Aged; Arrhythmias, Cardiac; Canrenoic Acid; Creatinine; Electrolytes; Female; Humans; | 1979 |
[Complications in null-diet].
Topics: Acetone; Adult; Allopurinol; Arrhythmias, Cardiac; Diet, Reducing; Edema; Female; Humans; Ischemic A | 1977 |
[Biochemical changes in the blood of calves with scours and their correction by fluid therapy (author's transl)].
Topics: Acidosis; Animals; Arrhythmias, Cardiac; Bicarbonates; Cattle; Cattle Diseases; Diarrhea; Glucose; H | 1976 |
Treatment with digoxin and measurement of serum digoxin levels after myocardial infarction.
Topics: Administration, Oral; Arrhythmias, Cardiac; Creatinine; Digoxin; Heart Arrest; Humans; Injections, I | 1975 |
The relationship between cardiotoxicity and plasma digoxin concentration in conscious dogs.
Topics: Animals; Arrhythmias, Cardiac; Calcium; Digoxin; Dogs; Electrocardiography; Female; Heart Block; Hea | 1976 |
Coronary prognostic index for the Chinese.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Blood Pressure; China; Female; Hu | 1987 |
Systemic lupus erythematosus induced by procaine amide.
Topics: Aged; Antibodies, Antinuclear; Arrhythmias, Cardiac; Blood Proteins; Blood Sedimentation; Humans; Im | 1970 |
Use of plasma levels in evaluation of procainamide dosage.
Topics: Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Body Weight; Cardiac Complexes, Premature; | 1974 |
Sedation for cataract surgery. Comparison of Carbrital and neuroleptanalgesia.
Topics: Aged; Apnea; Arrhythmias, Cardiac; Benperidol; Butyrates; Cataract Extraction; Fentanyl; Humans; Hyp | 1970 |
[Clinical features and treatment of carbromal poisoning].
Topics: Adult; Arrhythmias, Cardiac; Diuresis; Female; Follow-Up Studies; Humans; Lung Diseases; Male; Middl | 1972 |
Synthesis and antiarrhythmic activity of 5,5-disubstituted-3-aminoalkylhydantions and some heterocyclic and noncyclic analogues.
Topics: Alkylation; Amides; Animals; Arrhythmias, Cardiac; Diethylamines; Dimethylamines; Disopyramide; Hete | 1974 |
A prospective survey of the incidence of cardiac intoxication with digitalis in patients being admitted to hospital and correlation with serum digoxin levels.
Topics: Adult; Aged; Arrhythmias, Cardiac; Creatinine; Digoxin; Electrocardiography; Female; Hospitalization | 1973 |
Importance of pharmacokinetics and dosage in digoxin maintenance therapy. A retrospective analysis of serum digoxin levels.
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Digoxin; Female; Heart Failure; Humans; Iodine Radioisotope | 1974 |
Plasma digoxin levels in digitalized and toxic patients.
Topics: Arrhythmias, Cardiac; Digitalis Glycosides; Digoxin; Electrocardiography; Humans; Poisoning; Potassi | 1972 |
Rational use of drugs for cardiac arrest and after cardiac resuscitation.
Topics: Adams-Stokes Syndrome; Arrhythmias, Cardiac; Atropine; Bicarbonates; Blood Circulation; Electric Cou | 1971 |
Plasma digoxin concentrations and digoxin toxicity in hospital patients.
Topics: Administration, Oral; Adult; Age Factors; Aged; Arrhythmias, Cardiac; Coronary Disease; Digoxin; Ele | 1971 |